C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/28 (2006.01) A61K 31/505 (2006.01) C07D 239/42 (2006.01) C07D 239/48 (2006.01)
Patent
CA 2161325
Pyrimidine-cyanoguanidine compounds Formula (I) and its pharmaceutically acceptable acid addition salts wherein R1 is hydrogen or methyl; R2 is C1-C6 alkyl, C2-C6 alkenyl, C21-C6 alkynyl, C3-C5 cycloalkyl, C3-C5 cycloalkenyl, hydroxy methyl, methoxy C1-C5 alkyl, or R1 and R2 are combined to form a C3-C6 carbocyclic ring; R3 and R4 are each independently selected to be hydrogen, C1-C4 alkyl, F. Cl, Br, I or CF3; R5 is hydrogen, F or Cl; R6 is hydrogen, -NH2, -NHCH3, -NHC2H5, -NHCH(CH3)2, -N(CH3)2, -N(C2H5)2, NH(CH2)m-OC1-C3 alkyl (where m is 2 or 3), -NHC(O)C1-C3 alkyl, Cl or Br, and n is 0 or 1. The compounds of Formula I are potassium channel blockers useful in the treatment of cardiovascular disorders such as congestive heart failure and hypertension and as a diuretic.
L'invention concerne des composés de cyanoguanidine-pyrimidine de formule I et leurs sels d'addition d'acide pharmaceutiquement acceptables, formule dans laquelle R1 représente hydrogène ou méthyle; R2 représente alkyle C1-C6, alcényle C2-C6, alkynyle C2-C6, cycloalkyle C3-C5, cycloalcényle C3-C5, hydroxyméthyle, méthoxy-alkyle C1-C5, ou R1 et R2 sont combinés pour former un noyau carbocyclique C3-C6; R3 et R4 représentent indépendamment hydrogène, alkyle C1-C4, F, Cl, Br, I ou CF3; R5 représente hydrogène, F or Cl; R6 représente hydrogène, -NH2, -NHCH3, -NHC2H5, -NHCH(CH3)2, -N(CH3)2, -N(C2H5)2, NH(CH2)m-OC1-C3 alkyle (m correspond à 2 ou 3), -NHC(O)C1-C3 alkyle, Cl ou Br; et n correspond à 0 ou 1. Les composés de formule I sont des agents bloquants des vannes à potassium utilisés dans le traitement de troubles cardiovasculaires tels que l'insuffisance cardiaque congestive et l'hypertension, ainsi qu'en tant qu'agents diurétiques.
Hester Jackson B. Jr.
Humphrey Stephen J.
Ludens James H.
Meisheri Kaushik D.
Macrae & Co.
Pharmacia & Upjohn Company
LandOfFree
Pyrimidine, cyanoguandines as k-channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine, cyanoguandines as k-channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine, cyanoguandines as k-channel blockers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1723402